<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="94080" name="sirolimus (beta thalassemia/sickle cell disease), Rare Partners"><HDS>Discovery</HDS><RegulatoryDesignations><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation></RegulatoryDesignations><Actions><Action id="5715" type="primary">Hemoglobin synthesis stimulator</Action><Action id="10240" type="primary">mTOR inhibitor</Action></Actions><Indications><Indication id="2369" type="primary">Beta thalassemia</Indication><Indication id="303" type="primary">Sickle cell anemia</Indication></Indications><Entities><Entity>Chemical</Entity></Entities><OriginatorCompany id="1076546">Rare Partners Srl</OriginatorCompany></Drug>